The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Gastroenteropancreatic high‐grade neuroendocrine carcinoma
Abstract
Gastroenteropancreatic (GEP) neuroendocrine neoplasms are classified as low‐grade, intermediate‐grade, and high‐grade tumors based on morphologic criteria and the proliferation rate. Most studies have been conducted in patients with well differentiated (low‐grade to intermediate‐grade) neuroendocrine tumors. Data are substantially scarcer on poorly differentiated, high‐grade neuroendocrine carcinoma (NEC), which includes the entities of small cell carcinoma and large cell NEC. A literature search of GEP‐NEC was performed. Long‐term survival was poor even among patients who presented with localized disease. Several studies highlighted heterogeneity within the high‐grade NEC category and a need for the further identification of discreet prognostic and predictive groups. Tumors with a Ki‐67 proliferation index <55% were less responsive to platinum‐based chemotherapy, and patients with such tumors or with well differentiated morphology had better survival than patients who had tumors with poorly differentiated morphology or a higher Ki‐67 index. Treatment options beyond platinum‐based chemotherapy are emerging. A revision of the World Health Organization high‐grade NEC classification seems to be necessary based on recent data. Platinum‐based chemotherapy may not be the optimal treatment for patients who have GEP‐NEC with a moderately high proliferation rate. Adequate diagnostic and prognostic stratifications constitute the basis for future progress. Cancer 2014;120:2814–2823. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Self-citationPathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Sorbye, H., Welin, S., Langer, S. W., Vestermark, L. W., Holt, N., Osterlund, P., Dueland, S., Hofsli, E., Guren, M. G., Ohrling, K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds276 · Cited by 1,027
Self-citationMoertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Markou, K. D., Nikolaou, A. C., & Themelis, C. (2011) · Cited by 757
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Kunz, P. L., Reidy-Lagunes, D., Anthony, L. B., Bertino, E. M., Brendtro, K., Chan, J. A., Chen, H., Jensen, R. T., Kim, M. K., Klimstra, D. S., et al. (2013) · Pancreas · doi:10.1097/mpa.0b013e31828e34a4 · Cited by 580
Self-citationYachida, S., Vakiani, E., White, C. M., Zhong, Y., Saunders, T., Morgan, R., de Wilde, R. F., Maitra, A., Hicks, J., DeMarzo, A. M., et al. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182417d36 · Cited by 534
Self-citationFynn, R. W. (1959) · PubMed · Cited by 502
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
Self-citationBinderup, T., Knigge, U., Loft, A., Federspiel, B., & Kjaer, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1759 · Cited by 489
Garcia-Carbonero, R., Capdevila, J., Crespo-Herrero, G., Díaz-Pérez, J. A., Martínez del Prado, M. P., Alonso Orduña, V., Sevilla-García, I., Villabona-Artero, C., Beguiristain-Gómez, A., Llanos-Muñoz, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq022 · Cited by 419
Strosberg, J. R., Coppola, D., Klimstra, D. S., Phan, A. T., Kulke, M. H., Wiseman, G. A., & Kvols, L. K. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb56f · Cited by 359
Self-citationAre G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise, F.-L., Duvillard, P., Foucan, L., Hadoux, J., Chougnet, C. N., Leboulleux, S., Malka, D., Guigay, J., Goere, D., Debaere, T., et al. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0027 · Cited by 325
Self-citationSmall-Cell Carcinomas of the Gastrointestinal Tract: A Review
Brenner, B., Tang, L. H., Klimstra, D. S., & Kelsen, D. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.075 · Cited by 294
Self-citationWelin, S., Sorbye, H., Sebjornsen, S., Knappskog, S., Busch, C., & Öberg, K. (2011) · Cancer · doi:10.1002/cncr.26124 · Cited by 288
Self-citationPanzuto, F., Boninsegna, L., Fazio, N., Campana, D., Pia Brizzi, M., Capurso, G., Scarpa, A., De Braud, F., Dogliotti, L., Tomassetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0688 · Cited by 285
Binderup, T., Knigge, U., Loft, A., Mortensen, J., Pfeifer, A., Federspiel, B., Hansen, C. P., Højgaard, L., & Kjaer, A. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069765 · Cited by 279
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
Baudin, E., Gigliotti, A., Ducreux, M., Ropers, J., Comoy, E., Sabourin, J., Bidart, J., Cailleux, A., Bonacci, R., Ruffié, P., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.635 · Cited by 250
Self-citationKorse, C. M., Taal, B. G., van Velthuysen, M.-L. F., & Visser, O. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.022 · Cited by 239
Hainsworth, J. D., Spigel, D. R., Litchy, S., & Greco, F. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0575 · Cited by 185
Vortmeyer, A. O., Lubensky, I. A., Merino, M. J., Wang, C., Pham, T., Zhuang, Z., & Furth, E. E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1448 · Cited by 164
Hentic, O., Hammel, P., Couvelard, A., Rebours, V, Zappa, M., Palazzo, M., Maire, F., Goujon, G., Gillet, A., Lévy, P., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0002 · Cited by 162
Rare tumors of the colon and rectum: a national review
Kang, H., O’Connell, J. B., Leonardi, M. J., et al. (2006) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0145-2 · Cited by 153
Maru, D. M., Khurana, H., Rashid, A., Correa, A. M., Anandasabapathy, S., Krishnan, S., Komaki, R. R., Ajani, J. A., Swisher, S. G., & Hofstetter, W. L. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31816bf41f · Cited by 144
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases
Brenner, B., Shah, M. A., Gönen, M., Klimstra, D. S., Shia, J., & Kelsen, D. P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601758 · Cited by 141
Self-citationKlöppel, G., Heitz, P. U., Capella, C., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900021 · Cited by 128
Korse, C. M., Taal, B. G., Vincent, A. D., van Velthuysen, M. F., Baas, P., Buning-Kager, J. C. G. M., Linders, T. C., & Bonfrèr, J. M. G. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.012 · Cited by 122
Saxena, A., Chua, T. C., Sarkar, A., Chu, F., Liauw, W., Zhao, J., & Morris, D. L. (2010) · Surgery · doi:10.1016/j.surg.2010.06.008 · Cited by 110
Ku, G. Y., Minsky, B. D., Rusch, V. W., Bains, M. S., Kelsen, D. P., & Ilson, D. H. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm476 · Cited by 106
Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy
Ezziddin, S., Opitz, M., Attassi, M., Biermann, K., Sabet, A., Guhlke, S., Brockmann, H., Willinek, W. A., Wardelmann, E., Biersack, H., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1610-2 · Cited by 96
Brenner, B., Tang, L. H., Shia, J., Klimstra, D. S., & Kelsen, D. P. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.10.022 · Cited by 94
Self-citationEriksson, B. K., Annibale, B., Bajetta, E., Mitry, E., Pavel, M., Platania, M., Salazar, R., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225950 · Cited by 93
Extrapulmonary small cell carcinoma: Single center experience with 61 patients
Lee, S. S., Lee, J., Ryu, M., Chang, H. M., Kim, T., Kim, W. K., Lee, J. S., Jang, S.-J., Khang, S. K., & Kang, Y. (2007) · Acta Oncologica · doi:10.1080/02841860601071893 · Cited by 89
Genetic evidence for the multi-step progression of mixed glandular–neuroendocrine gastric carcinomas
Kim, K., Kim, M., Cho, B.-K., Choi, S., & Rhyu, M. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100540 · Cited by 88
Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms
Cho, C. S., Labow, D. M., Tang, L. H., Klimstra, D. S., Loeffler, A. G., LEVERSON, G. E., Fong, Y., Jarnagin, W. R., D'Angelica, M. I., Weber, S. M., et al. (2008) · Cancer · doi:10.1002/cncr.23523 · Cited by 81
Self-citationEuropean disparities in malignant digestive endocrine tumours survival
Lepage, C., Ciccolallo, L., Angelis, R. D., Bouvier, A., Faivre, J., Gatta, G., & The EUROCARE working group (2009) · International Journal of Cancer · doi:10.1002/ijc.24698 · Cited by 79
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Janson, E. T., Sørbye, H., Welin, S., Federspiel, B., Grønbæk, H., Hellman, P., Mathisen, Ø., Mortensen, J., Sundin, A., Thiis‐Evensen, E., et al. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.492791 · Cited by 75
Faggiano, A., Sabourin, J., Ducreux, M. P., Lumbroso, J., Duvillard, P., Leboulleux, S., Dromain, C., Colao, A., Schlumberger, M. J., & Baudin, É. (2007) · Cancer · doi:10.1002/cncr.22791 · Cited by 68
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract
Pizzi, S., Azzoni, C., Bassi, D., Bottarelli, L., Milione, M., & Bordi, C. (2003) · Cancer · doi:10.1002/cncr.11621 · Cited by 66
Karkouche, R., Bachet, J., Sandrini, J., Mitry, E., Penna, C., Côté, J.-F., Blons, H., Penault-Llorca, F. M., Rougier, P. R., Saint‐André, J., et al. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283583c87 · Cited by 64
Terashima, T., Morizane, C., Hiraoka, N., Tsuda, H., Tamura, T., Shimada, Y., Kaneko, S., Kushima, R., Ueno, H., Kondo, S., et al. (2012) · Neuroendocrinology · doi:10.1159/000338794 · Cited by 62
Garske, U., Sandström, M., Johansson, S., Granberg, D. O., Lundqvist, H., Lubberink, M., Sundin, A., & Eriksson, B. K. (2012) · Theranostics · doi:10.7150/thno.3594 · Cited by 29
Are Neuroendocrine Tumors Going Mainstream?
Kulke, M. H. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3884 · Cited by 12
Fazio, N., Grana, C. M., Pelosi, G., Torrisi, R., Meglio, G. D., Tradati, N., Lorizzo, K., & de Braud, F. (2006) · Acta Oncologica · doi:10.1080/02841860500544909 · Cited by 7
(1997) · doi:10.1002/(sici)1097-0142(19970501)79:9
Cited by
Pavel, M., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,179
Pavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Oronsky, B., Ma, P. C., Morgensztern, D., & Carter, C. A. (2017) · Neoplasia · doi:10.1016/j.neo.2017.09.002 · Cited by 763
Garcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., et al. (2016) · Neuroendocrinology · doi:10.1159/000443172 · Cited by 611
Self-citationEpidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
Das, S., & Dasari, A. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01029-7 · Cited by 391
Metadata
- Authors
- Sorbye, H., Strosberg, J., Baudin, E., Klimstra, D. S., & Yao, J. C.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-04-25
- Volume
- 120
- Issue
- 18
- Pages
- 2814-2823
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1555094309
- Cited by
- 347
- References
- 47
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.